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ABSTRACT 
 
The measurement of fluctuating level of neurotransmitters present in the living 
brain is critical to understanding the functioning of the brain, and more 
importantly, to restoring normal function to the brain with abnormal activity via 
Deep Brain Stimulation (DBS).  It is anticipated that utilizing a feedback approach 
to controlling neurotransmitter levels may provide a way of treating more 
disorders of the brain where controlling a level or range of concentration of 
neurotransmitters would be beneficial, rather than providing a maximum level, 
which may lead to other medical issues.  The primary thrust of this thesis is: How to 
create Fast Scan Cyclic Voltammetry (FSCV) sensing electrodes suitable for long 
term implantation in the human brain?  My central hypothesis is that Boron doped 
diamond is suitable for long term FSCV recordings in the human brain for 
measurements of neurotransmitter release demonstrated during DBS 
neurosurgery.  This research develops boron doped diamond electrodes to 
measure neurochemical changes via fast scan cyclic voltammetry in the living 
human brain during deep brain stimulation. First, the importance of electrodes as 
the point of interface between the human biology and engineered electronic 
systems is described, providing the background for current technological state of 
art in stimulation and sensing electrodes.  Then, the electrochemical technique of 
fast scan cyclic voltammetry, the engineering design, and capabilities of the Mayo 
developed Wireless Instantaneous Neurotransmitter Concentration System 
(WINCS) and Mayo Investigational Neurostimulation Control System (MINCS) are 
presented.  In line with electronics development, new methods and technology that 
lead to the engineering development of WINCS Harmoni, which can measure and 
characterize real time in-vivo changes in neurochemical activity across multiple 
anatomical targets and can provide real-time feedback to control neurochemical 
levels, are described.   Next, the development and operation of the chemical reactor 
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system used to create the boron doped diamond electrode are given.  The thesis 
then presents the work on analyzing the diamond film structure and boron doping 
of the active component of the electrode, describes the metal like behavior of 
diamond containing boron using techniques of spectroscopy, and evaluates the 
incorporated stress and strain in the diamond film allowing evaluation of long term 
stability of the substrate/diamond interface.  The final component of this thesis is 
the exciting application of the diamond-based electrode for measurement of 
neurochemicals released in the human brain during DBS neurosurgery.  It is 
planned that this development of an electrode that is usable in humans will provide 
the breakthrough to allow the creation of DBS with feedback to be used to manage 
current application of DBS in neurologic and psychiatric diseases.   Finally, the 
work that has been presented in this thesis provides the road map for fully 
implantable therapeutic closed loop DBS devices, allowing precision control of 
human neurotransmitter systems. 
 
The major contributions from this thesis include the following: 
1. Boron doped diamond is suitable for FSCV sensing using the novel WINCS 
monitoring devices. 
2. Boron doped diamond has the necessary longevity to allow implantation for 
long term human implantation. 
3. Adenosine was indeed released during DBS lead insertion in human patients 
as measured by WINCS and carbon fiber microelectrode and boron doped 
diamond. 
4. The boron doped diamond can be fabricated in high volume using our novel 
diamond reactor. 
5. It is possible to develop feedback loop sensors using boron doped diamond 
electrodes. 
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CHAPTER 1: INTRODUCTION
The living brain operates via a complex, minimally understood 
combination of electrical and chemical signals.  The electrical signals 
have been measured for many years for research and clinical uses, 
since access to those signals is rather straightforward.  However, 
chemical signaling is still being elucidated and is critical to developing 
understanding of brain function.  Abnormal brain function is also a 
combination of electrical and chemical signals, and contrasting normal 
and abnormal activity is key to developing technologies and treatment 
for restoring normal function to the brain. 
 
There are a number of neurologic conditions that cause great 
difficulty for individuals which can be treated with Deep Brain 
Stimulation (DBS).  Current DBS technology, which is open loop, or 
without feedback, has been implanted in approximately 150,000 
patients worldwide.  The disease states approved for treatment with 
DBS by the FDA (United States Food and Drug Administration)are 
Parkinson’s Disease (brain target: Subthalamic Nucleus (STN), Globus 
Pallidus, Internal Segmant (GPi)), Dystonia (GPi), and Tremor (Vim 
Thalamus), Obsessive Compulsive Disorder (Ventral capsule/Ventral 
Striatum).  Further, it is an emerging treatment for Epilepsy (Anterior 
Thalamus), Tourette’s Syndrome (Central Median (CM) Thalamus), 
Depression (Area 25) (1), Chronic Pain (Peri Aquaductal Grey (PAG)/ 
Peri Ventricular Grey (PVG), Thalamus), Obesity (Hypothalamus), 
Addiction (Nucleus Accumbens (NAc)) and others are being examined 
(2).  Locations of these targets are shown in Figure 1-1 and additional 
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target areas for other neurologic and psychiatric disorders are listed 
in Table 1-1. 
DBS is thought to provide stimulation by injecting electrical signals 
superimposed upon the existing electrical signals of the brain, with 
the goal of preventing abnormal signals from modifying desired 
physical movement and psychological behavior.  The actual 
mechanism of action is as of yet, unknown. Despite this lack of 
knowledge, DBS treatment has been demonstrated to be highly 
effective. Indeed, for many patients whom medications are not able to 
control the symptoms, DBS provides a substantial improvement in 
symptoms or return to normal behavior (3). 
 
The DBS method involves  injecting charge balanced electrical pulses 
at a selected precise location in the brain to modify the operation of 
neural circuits (4).  The device used to achieve this is comprised of an 
implantable pulse generator (IPG) and batteries, typically 
programmable, with the ability to designate voltage (up to 10.5 v), 
duration (up to 450 microseconds) and frequency (up to 250 Hz) (5, 
6).  The IPG is connected to a set of two stimulation electrodes 
(although sometimes one electrode is implanted for one target) with 
the electrode material typically of a platinum-iridium alloy that is 
precisely placed in a deep brain structure selected by the 
neurosurgeon to provide the best outcome for the neurological issue.  
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Figure 1-1: High resolution 7 tesla Magnetic Resonance Images (MRI) of the 
human brain, identifying subthalamic nucleus (STN), which is a target for 
Parkinson’s disease.   (STN= Subthalamic Nucleus, SN= Substantia Nigra, Cl= 
Claustrom, Pu= Putamen, GPe= Globus Pallidus, Externa, GPi= Globus 
Pallidus, Internal Segment, 3V= Third Ventricle, PCA= Posterior Cerebral 
Artery)  Source: Mayo Neural Engineering Laboratories. 
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Table 1-1:  Typical stimulation electrode locations for treatment of various 
neurologic and psychiatric disorders. (Lee, KH, Handbook of Deep Brain 
Stimulation, Pan Stanford Publishing, in Press.) 
Stimulation Location 
 Abbreviation Disorders 
Anterior Thalamus  Epilepsy 
Area 25  Depression 
Centromedian Thalamus CM Thalamus 
Tourette’s 
Syndrome 
Globus Pallidus, Internal 
Segment 
GPi Dystonia 
Globus Pallidus, External GPe 
Tourette’s 
Syndrome 
Motor Cortex  Chronic Pain 
Nucleus Accumbuns NAc 
Obsessive 
Compulsive 
Disorder 
Peri Aquaductal Grey PAG Chronic Pain 
Peri Ventricular Grey PVG Chronic Pain 
Subthalamic Nucleus STN 
Parkinson’s 
Disease 
Fornix  Memory 
Ventralis Intermedius Thalamus Vim Thalamus Essential Tremor 
 
 
The current DBS technology is of open loop control and requires 
continued evaluation by a medical professional for maintaining 
therapeutic value.  The procedure is to evaluate medically important 
signs which indicate whether the stimulation is as effective as 
planned.  For instance, by observing increased tremor, or return of 
tremor, a remote control device is used to modify the electrical 
settings of the DBS Implantable Pulse Generator (IPG) to control the 
electrical impulses delivered to the brain and improve clinical 
outcome.  For psychiatric issues, a medical professional needs to 
identify any recently emergent behaviors, and modify the stimulation 
as psychiatrically appropriate.   
 
The proposed improvement in DBS is to measure and understand the 
level of neurotransmitters in the brain and utilize an algorithm to 
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modify stimulation parameters in real time, for the best medical 
outcome.  This research is to develop a boron doped diamond based 
electrode and feedback control loop electronic system that is capable 
of long term Fast Scan Cyclic Voltammetry (FSCV) based sensing and 
stimulation.  
 
It is anticipated that utilizing a feedback approach to control 
neurotransmitter levels may provide a way of treating more disorders 
of the brain, especially psychiatric disorders such as depression, which 
appears to require neurotransmitter modulation.  Of the methods for 
measuring the effect of brain stimulation which is typically applied 
from five to several hundred times per second, only a very fast 
measurement process will provide the time resolution to examine the 
effect of DBS (7).  FSCV is the only technique currently known to 
provide near real time (9.5 ms) determination of changes in 
concentration of neurotransmitters which can be then be used as a 
feedback variable in a control system. 
 
Dopamine and adenosine were chosen as the major analytes of interest in 
this thesis.  The rational for selecting these neurotransmitters is: 
1. Both neurochemicals have been shown to be important in human 
brain function and disease.
2. Adenosine has been implicated in mediation of Deep Brain 
Stimulation for tremor (8).
3. Dopamine is critical for Parkinson’s disease, during the 
progression of which the substantia nigra and pars compacta degenerate.
4. Both neurochemicals are electrochemically active and can be 
measured by FSCV.
 
The present research is aimed at improving the sensing electrode 
surface to provide a sensor that can last the life of the patient, on the 
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order of 30 years of implantation.  Creating a custom diamond 
deposition reactor in this research will allow the exploration of 
diamond characteristics critical for the electrode. Comparison with the 
characteristics of the current “gold standard” electrode (pyrolytic 
carbon) in order to identify alternative materials, will provide the key 
characteristics which include carbon content to allow adsorption of the 
electroactive neurochemicals, oxidation resistance to prevent 
dissolution of the electrode in the presence of oxygen radicals, 
electrical conductivity, biocompatibility and physical strength for 
implantation.  The evaluation of all these requirements leads to 
diamond as the logical choice, except for the electrical conductivity 
requirement, in that diamond is a known electrical insulator.  However, 
it is also known that certain diamonds, specifically blue diamonds, are 
electrically conductive due to elemental boron incorporated in the 
carbon crystal lattice providing free electrons, hence the blue 
coloration and  electrical conductivity. Therefore, polycrystalline 
diamond films which are boron doped were the primary candidates for 
the replacement of pyrolytic carbon fibers. Within the laboratories at 
Mayo Clinic, the author developed the hypothesis for this material, has 
designed and built a Chemical Vapor Deposition (CVD) diamond 
reactor for the production of thin doped diamond films on tungsten 
and silicon substrates and continues to develop this technology in the 
context of ongoing research in DBS and the goal of developing a 
feedback loop system.  Results to date and the literature indicate that 
boron doped diamond films are producible with suitable conductivity 
for the preparation of electrodes that are both sensitive and durable 
for next generation closed-loop human DBS systems for chronic in vivo 
use for human treatments. 
 
DBS is a treatment of disease states, rather than a cure of disease or 
abnormal function.  Because of this, the DBS equipment and 
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electrodes will need to be functional for the balance of the patient’s 
life.  It is anticipated that the implanted devices will need to last about 
30 years with sufficient sensitivity to maintain treatment.  The 
technique being explored in this thesis, FSCV, allows near real time 
quantification of catecholamine neurotransmitters, their metabolites 
and other electroactive analytes. Currently, no technology exists for 
closed loop DBS in substantial part due to the fragility of the current 
standard, carbon fiber (pyrolytic carbon), and the physical and 
sensitivity degradation during certain analyses as reported by 
Takmakov et al (9). 
 
 
 
 
Research Question 
 
The central research question is as follows: 
How can Fast Scan Cyclic Voltammetry sensing electrodes 
suitable for long term implantation in the human brain be 
created? 
 
The Statement of the central hypothesis is as follows: 
Boron doped diamond is suitable for long term FSCV recordings 
in the human brain for measurements of neurotransmitter 
release demonstrated during DBS neurosurgery.  
 
This research work aims to design and develop FSCV sensing 
electrodes that, for the first time, will be based on boron doped 
diamond and that will be suitable for long term implantation in the 
brain.  Novel electrode compositions that will allow the quantitative 
measurement of neurotransmitter release for sustained periods of 
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time will be developed and tested.  At this time it is not known what 
the optimal level of these neurotransmitters for the necessary 
feedback for improvements in Deep Brain Stimulation.  Discovery of 
this information is also one of the major goals of future work based 
upon these electrodes and FSCV systems. 
 
While boron doped diamond electrodes have been developed for 
electrochemical sensing, they have been limited to use for periods of 
hours, potentially days at low usage intensity in vitro and in vivo 
(predominately rats and brain slice), but not in humans (9).  For 
substantial contributions to science and medical care, FSCV electrodes 
need to be active for much longer periods, measured in decades.  This 
research work will determine electrode fabrication techniques that 
will demonstratably result in the ability of the electrodes to function 
for the millions of cycles that will characterize a long term study, and 
the successful measurement of neurotransmitters in the brain. 
 
The development of an electrode that is usable in humans will provide 
the breakthrough needed to allow the creation of DBS with feedback 
to be used to manage psychiatric diseases. 
 
1.1  FAST SCAN CYCLIC VOLAMMETRY (FSCV) 
FSCV is a form of voltammetry in which a varying electrical potential 
is applied to a sensing electrode in a specific pattern.  Precise 
measurement of the current flow (typically in nanoamperes) through 
the electrode provides for the detection of a chemical signature for 
identifying specific electroactive molecules of interest.  As an example 
of the detection of dopamine, as a positive voltage is applied to a 
carbon based electrode, oxidation of the adsorbed dopamine occurs at 
+0.6 volts to dopamine-o-quinone (DOQ), followed by reduction back 
to dopamine at -0.2 volts.  Typically, for biological detection of the 
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dopamine neurotransmitter, a triangular voltage waveform from -0.4 
to +1.5 is applied to the electrode. The pattern of change in current 
flow at certain voltages is specific to specific chemicals.  The current 
flow can be used to determine change in concentration by background 
subtraction (10-13) and interpolation with a linear function. Figure 1-
2, below, shows these measurements for dopamine, adenosine and the 
combination, demonstrating how multiple neurochemicals can be 
detected at the same time since the oxidation and reduction peaks 
occur at different voltages. 
 
Figure 1-2: FSCV detection of dopamine, adenosine and simultaneous 
detection utilizing a carbon fiber microelectrode in vitro.  The color plots 
show the three dimensional plot of nanoamperes (color), applied voltage 
and time for the respective detections of neurochemicals.  The applied 
potential of -0.4 volts scanning to +1.5 volts and lasting 9.5 ms, at 400 V per 
second occurred every 100 ms.   The traces in the bottom half of the figure 
show the data collected indicating the oxidation peaks as well as the 
reduction peaks of the electrochemistry.  A) Shows the detection of 1.5 
micro molar dopamine in a flow cell at 5 seconds from the initiation of data 
collection. B) Shows the detection of 5 micro molar adenosine and C) the 
simultaneous detection of both neurotransmitters is easily differentiated. 
Source: Mayo Neural Engineering Laboratories. 
 
Specific parameters of detection for the neurotransmitters dopamine, 
adenosine, serotonin and glutamate are shown in Table 1-2, below.  
FSCV can also be used to detect norepinephrine, epinephrine, 
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histamine, nitric oxide and pH shift (9, 14-17).  The table lists the 
detection by FSCV as well as amperometry. 
 
Table 1-2: Summary of FSCV and amperometry (AMP)detection parameters 
describing neurotransmitters, the mode of detection, voltage excursion and 
scan rates among other information )(7). 
Neurochemical Mode Wave Parameters (V) Scan Rate (V/sec)
Oxidation 
Peaks (V)
Reduction
Peaks (V)
dopamine FSCV Vshape -0.4Æ+1.3Æ-0.4 400 +0.6 -0.2
dopamine AMP +0.8
adenosine FSCV Vshape -0.4Æ+1.5Æ-0.4 400
+1.4, 
+1.0, +0.5
adenosine AMP +0.5Æ0.6
serotonin FSCV Nshape
+0.2Æ+1.0Æ
-0.1Æ+0.2 1000 +0.8 0
glutamate AMP +0.5Æ0.6
*AMP = amperometry; sec = second.
 
A related electrochemical technique, fixed-potential amperometry 
(AMP in Table 1-2) measures current at a constant potential (voltage). 
By using one or more enzymes linked to the electrode, typically a 
reporter molecule, hydrogen peroxide, is created through the 
enzymatic oxidation of the target chemical, and the resultant 
concentration of hydrogen peroxide is measured. This enzymatic 
process allows the detection and measurement of non-electroactive 
chemicals such as glutamate. The electrode composition typically is a 
platinum metal alloy, which in this example, is coated with glutamate 
oxidase, which is specifically reactive with glutamate. While the speed 
of detection is fast (1-1000 microseconds) the enzyme eventually 
becomes non-reactive, and therefore the electrode must be replaced 
(7). 
 
A variety of technical limitations has prevented FSCV from providing 
the information necessary for feedback loop controlled DBS for long 
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term implantation in animal models or humans.  Key among the issues 
is the longevity of the active surface of the FSCV electrode for 
measuring neurotransmitter levels.  Current sensor technology for in 
vivo use, utilizes pyrolytic carbon in the form of a carbon fiber which 
has been used successfully at low voltage potentials, but at higher 
impressed voltages, such as those required for the detection of 
adenosine (up to +1.5 volts).  The lifetime of FSCV electrodes in 
continuous use has been found by the Mayo Neural Engineering 
Laboratories to be measured in days rather in years that would be 
necessary for a practical electrode for human treatment.  Figure 1-3  
fiber (pyrolytic carbon) microelectrode, which initially provides 
substantial signal. Figure 1-4 shows the initial color plot of the FSCV 
data for the detection of dopamine. Figure 1-5 shows the color plot of 
FSCV data for an attempt to detect dopamine using the same sensing 
fiber of Figure 1-4 after three days of use.  The signal is degraded to 
the extent that detection of neurochemicals is not possible. 
 
 
Figure 1-3: Carbon fiber microelectrode, end view. Unused on left, used for 
one day on right, showing start of erosion due to use. Source: Mayo Neural 
Engineering Laboratories. 
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Figure 1-4: Color plot of  FSCV analysis of dopamine using carbon fiber 
electrode.  Strong signal is present. Source: Mayo Neural Engineering 
Laboratories. 
 
 
 
Figure 1-5: Color plot of FSCV analysis of dopamine using the same carbon 
fiber electrode utilized for Figure 1-4, after three days of use.  Note almost 
complete absence of signal indicated by lack of intense color. Source: Mayo 
Neural Engineering Laboratories. 
 
FSCV is a highly time resolved technique of using oxidation/reduction 
chemistry to identify and measure concentrations of electroactive 
chemicals. The speed of measurement is similar to the activity of 
biological reactions and is capable of elucidating neurotransmitter 
dynamics in vivo (18).  The field of FSCV employs various chemical 
sensors that have been utilized for decades, however the micrometer 
sized sensors utilized in this work have a history starting in the 
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1980’s (19). The technique can be used to discover chemical changes 
occurring on the surface of single cells or even during the activity of 
the brain.  During the transmission of nerve impulses, neurons release 
neurotransmitters by a process called exocytosis.  These 
neurotransmitters are released at the synapse, or physiologic 
connection between neurons that has a gap that is on the order of 10-
100 nanometers. Upon release, the neurotransmitters diffuse across 
the junction, bind to receptors and thereby transfer information or 
signals between neurons. The cellular system immediately starts 
reabsorbing the neurotransmitters to restore a resting state that has  
a very low level of free neurotransmitters. 
 
A simplified description of the process of electroactive chemical 
detection via FSCV is for neurotransmitters to diffuse from the 
neuronal synapses to the carbon fiber microelectrode. An impressed 
voltage pulse arrives every 100 ms, and oxidation, followed by 
reduction occurs.  Nanoampere currents are detected, and a 
previously measured background current is subtracted from them.  
The resultant voltammogram is utilized to detect and report 
concentrations of the analyte of interest, based upon calibrations. 
 
1.2 SUMMARY OF RESEARCH
This work aims to develop a robust and biocompatible implantable 
electrode for chronic neurochemical sensing. Not only would it enable 
long-term studies of the neurochemical mechanisms of DBS in 
preclinical models, but ultimately it could be used within a closed loop 
system for human DBS. Such a system would have the capacity to 
adapt to the physiologic needs of the patient in accordance with 
neurochemical feedback identified through the characteristic 
oxidation/reduction of analytes at the electrode surface. Currently, 
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the un-monitored open loop DBS system has been implanted over 
150,000 times in humans, since the technique’s development in the 
1980’s. A ‘smart’ DBS system, encompassing electrodes for 
stimulation, coupled with FSCV electrodes positioned at different 
positions than the stimulation electrode within the brain to measure 
neurotransmitter changes, coupled with algorithms to manage 
stimulation, would greatly enhance and extend the clinical utility of 
DBS for movement disorders and, more importantly, neuropsychiatric 
disorders, especially depression. While DBS is the near term 
opportunity, it can be imagined that, akin to insulin pumps, 
pharmacotherapies could be microinjected via an implantable device 
into regions of interest based on real time neurochemical assay 
 
It is proposed to develop sensing electrodes based on electrically 
conductive diamond that will be suitable for long term implantation in 
the brain. Novel electrode systems that will allow more accurate and 
quantitative measurement of neurotransmitter release over sustained 
periods of time (months) will ultimately be developed and tested.  A 
diamond reactor must be created as part of this research to create the 
novel electrodes. 
 
The next chapters of this document will explore existing electrodes for 
neural use to identify valuable characteristics of the implantable 
electrode and the means to achieve creation of the device.  The report 
will discuss the characteristics and evaluation of the desired boron 
doped diamond coating, the significant research needed to create the 
reactor for the coating and will discuss the active electrode material 
(diamond) biocompatibility. 
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1.3 THESIS ORGANIZATION 
In Chapter 2, the work that was accepted for publication in the 
Handbook of Deep Brain Stimulation entitled “Electrodes for Neural 
Stimulation and Monitoring” is presented. This chapter describes the 
importance of electrodes as points of interface between human 
biology and engineered electronic systems. This work provides the 
background for current technological state of art in stimulation and 
sensing electrodes. 
 
In Chapter 3, the work that was accepted for publication in the 
Handbook of Deep Brain Stimulation entitled “Electrochemical 
Measurement of Neurochemcial Concentrations” is presented. This 
chapter describes the electrochemical technique of fast scan cyclic 
voltammetry. Further, it also describes the engineering design and the 
capabilities of the Mayo developed Wireless Instantaneous 
Neurotransmitter Concentration System (WINCS) and Mayo 
Investigational Neurostimulation Control System (MINCS).  This work 
provides the background for current state of the art in electronics for 
FSCV and neurostimulation. 
 
In Chapter 4, the work that has been submitted for publication in 
Nature Methods entitled “WINCS Harmoni: Closed-loop dynamic 
neurochemical control of therapeutic interventions” is presented.  
This chapter describes new methods and technology in the areas of 
neuromodulation and the treatment of neurologic and psychiatric 
disorders.  The author has led the engineering efforts for the 
development of WINCS Harmoni, which can measure and characterize 
real time in-vivo changes in neurochemical activity across multiple 
anatomical targets and can provide real-time feedback to control 
neurochemical levels.    
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In Chapter 5, the work that has been published in the Proceedings of 
the 60th Symposium on the Art of Scientific Glassblowing entitled 
“Chemical Vapor Deposition Reactor for Diamond Deposition” is 
presented. This chapter describes the development and operation of 
the chemical reactor system used to create the boron doped diamond 
electrode. The author conceived of the idea for use of boron doped 
diamond for human electrochemical detection.  The author then 
designed and developed the reactor system and created the active 
electrode for neurochemical detection. 
 
In Chapter 6, the work that has been published in Materials entitled 
“Development of Conductive Boron-Doped Diamond Electrode: A 
Microscopic, Spectroscopic, and Voltammetric Study” is presented. 
This chapter describes the analysis of the diamond film structure and 
boron doping of the active component of the electrode.   
 
In Chapter 7, the work that has been published in the Journal of 
Material Science entitled “A Drude model analysis of conductivity and 
free carriers in boron-doped diamond films and investigations of their 
internal stress and strain” is presented. This chapter describes the 
metal like behavior of diamond containing boron, using techniques of 
far infra-red spectrometry. This provides an understanding of the 
electron mobility, providing the conductivity necessary for FSCV.  
Further, this technique provides the evaluation of incorporated stress 
and strain in the diamond film, allowing evaluation of long term 
stability of the substrate/diamond interface. 
 
In Chapter 8, the work that has been published in the journal 
Materials entitled “Raman Microscopic Analysis of Internal Stress in 
Boron-Doped Diamond” is presented. This chapter utilizes the 
technique of confocal Raman microscopy, correlating chemical 
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composition of the diamond film and substrate used during 
fabrication of the electrode.  This proves the information relative to 
longevity and concerns of film delamination and dislocation. 
 
In Chapter 9, this paper describes the optical techniques of 
neurochemical detection utilizing Raman Spectroscopy that was 
envisioned during the Raman analysis of diamond described in 
Chapter 8.  This work will continue as additional research for the 
future.  Portions of this work have been published in Neuromodulation 
entitled “Detection and Monitoring of Neurotransmitters – a 
Spectrocopic Analysis.” 
 
In Chapter 10, the work that has been published in Frontiers in Human 
Neuroscience entitled “A Diamond-Based Electrode for Detection of 
Neurochemicals in the Human Brain” is presented. This chapter 
describes the culmination of all of the author’s research in 
development of boron-doped diamond electrode for measurement of 
neurochemicals released in the human brain during DBS 
neurosurgery.  This work also compares the conventional carbon fiber 
electrodes to the durable synthetic boron doped diamond based 
electrodes. 
 
In Chapter 11, the concluding remarks, the future direction for 
detection of neurotransmitters and its use for development of closed 
loop DBS.  
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CHAPTER 2: INVESTIGATION OF 
ELECTRODES FOR NEURAL 
STIMULATION AND MONITORING 
 
An examination of current electrode systems for DBS and monitoring 
of brain function provides important insights into the performance 
and problems of the existing technology.   
 
In development of a long term electrode for application of FSCV, the 
major requirement is suitable electro activity and stability of the 
sensing surface.  In addition, what will be needed is a structure which 
allows the precision positioning in the correct area of the brain, and 
for chronic use, a compliable structure to prevent additional damage 
to the brain caused by structural incompatibility due to the stiffness of 
the electrical connection to the sensing tip. 
2.1 BACKGROUND OF THE ELECTRODE SYSTEM 
The electrode system plays the crucial role as the point of interface 
between an engineered electronic system and natural biological 
tissue. While an electrode may be as simple as a section of exposed 
conductive material, in practice, an array of considerations constrains 
the engineering of practical neural electrodes.  Among these 
considerations are size and shape, current density, electronic 
impedance, surface chemistry, material biocompatibility, 
lifetime/longevity, and surgical practicality of installation and 
removal. 
 
Electrodes also differ in terms of use, corresponding to the intended 
direction of electrical current and information derived from their use.  
Some electrodes are purely passive and serve only to monitor and 
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record endogenous voltages (signals), or electrophysiology.  In this 
case, current and therefore information flows from the biological 
tissue through the electrode to the electronic system.  Other 
electrodes are designed for voltage (and therefore current) to be 
applied by the electronic system to neural tissue for the purpose of 
stimulation.  Finally, there are electrodes designed to serve both 
purposes or to serve a hybrid purpose.  For example, in FSCV, a small 
transient voltage is applied for the purpose of neurotransmitter 
concentration monitoring via oxidation/reduction chemistry, with a 
measurement of current flow. Here, the electronic system applies a 
voltage to a carbon based electrode within neural tissue, for 
diagnostic and monitoring purposes rather than for the purpose of 
neural stimulation. 
 
2.2 NEURAL ELECTRODE DESIGN CONSIDERATIONS 
The most obvious differences between neural electrode designs are 
the material of construction, the size and shape of the entire electrode, 
and of its individual electrical contacts.  Electrodes differ in the 
number of distinct (electrically-isolated) contacts or “channels” they 
contain: generally from one to dozens.  Electrodes with more channels 
allow for more distinct parts (contiguous volume) of the brain or 
nerve to be stimulated or monitored, but electrodes with more 
channels may be larger (and may therefore be more difficult to 
implant and more disruptive to their host tissue).  Electrodes with 
many channels are also more difficult to fabricate and require more 
complex wiring, connectors, and interface electronics. 
 
Each distinct electrically-isolated channel of an electrode is associated 
with an electrical conductor that electrically interfaces with the neural 
tissue. The size of this conductor impacts the area of neural tissue that 
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is in contact with the electrode, and hence the volume of associated 
tissue stimulated or sampled and the spatial precision of the 
stimulation or monitoring.  Electrode sizes can vary from low single-
digit micrometers (10-6 m) to low single-digit millimeters (10-3 m).  
Electrodes at the smaller end of this spectrum are capable of 
interacting with individual neurons, but tend to be very fragile, short-
lived, and yield weak (high impedance) signals that are suitable only 
for monitoring or research use.  Electrodes at the larger end of this 
spectrum are more robust and more suited for chronic surgical 
implantation into patients for purposes of stimulation. 
 
The size (area) of an electrode also affects its electrical properties.  In 
the case of stimulating electrodes, larger electrodes deliver current 
over a larger area, thus decreasing the “current density” (the number 
of electrons flowing between the electrode and the tissue per unit 
area per unit time).  This is important as high applied current 
densities may damage the electrode, the neural tissue, or both.  On the 
other hand, excessively large electrodes may stimulate too large of a 
volume, leading to undesirable off-target effects. 
 
Advanced stimulation electrodes can be constructed to apply different 
voltages to a patterned array of channels so as to “steer” the resulting 
electrical field in a defined way.  This technique can be used to refine 
the volume that is subject to stimulation (20). 
 
Monitoring/recording electrodes, are faced with a problem of small or 
weak signals, on the order of 100 microvolts for invasive 
electrophysiological methods (21). The amount of electrical charge 
produced endogenously by the brain or other neural tissue is 
comparatively small – i.e., it is a high-impedance voltage source and 
cannot deliver a large current.  An excessively large monitoring 
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electrode would act as a capacitor, therefore requiring too much 
charge to change its potential, leading to a slow dynamic response and 
temporally-ambiguous data (i.e., the electrode would act as a low-pass 
filter).  Additionally, large electrodes monitor a large number of 
neurons with potentially heterogeneous behavior, leading to spatially-
ambiguous data.  On the other hand, excessively small electrodes lead 
to higher impedance (as well as higher thermal noise) which reduce 
data quality (22). 
 
Electrodes are also commonly formed into multi-conductor arrays so 
as to monitor or introduce electric potentials over a grid of points.  By 
recording voltages at several adjacent points in the grid, triangulation 
can be used to estimate the position of individual active neurons – 
even if the neuron in question is not in direct contact with one of the 
grid point contacts. 
 
For more in depth discussion, the following Chapter 20 of the 
Handbook of Deep Brain Stimulation entitled “Electrodes for Neural 
Stimulation and Monitoring” is included.  
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CHAPTER 3: FAST SCAN CYCLIC 
VOLTAMMETRY (FSCV) 
 
FSCV in the laboratory is practiced for the detection of various 
neurochemicals and neurotransmitters, including dopamine, by 
specifically scanning a triangular wave form from -0.4 volts to 1.5 
volts at a rate in the range of 200-500 volts per second (for 
dopamine). The electrode historically is constructed by placing a 
carbon fiber (7 microns in diameter) within a glass capillary and, after 
softening the glass with heat, pulling to form a glass sheath around the 
fiber, and trimming the carbon fiber beyond the glass insulation to a 
size approximately 100 microns long. The associated electronics 
record the flow of current in nanoamperes and the analytical signal is 
extracted from the background signal by subtraction.  Systems 
utilized to make these measurements include the commercial 
equipment made by Universal Electrochemistry Instrument (UEI) 
(UEI; Department of Chemistry Electronic Shop, University of North 
Carolina), or the in-house designed and built system from the Mayo 
Clinic Division of Engineering, the Wireless Instantaneous 
Neurotransmitter Concentration System (WINCS) unit (10). 
 
More detailed discussion is provided in the included Chapter 19 from 
the Handbook of Deep Brian Stimulation, “Electrochemical 
Measurement of Neurochemical Concentrations.” 
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CHAPTER 4: WINCS HARMONI 
DEVELOPMENT  
 
The following work has been submitted for publication in Nature 
Methods entitled “WINCS Harmoni: Closed-loop dynamic 
neurochemical control of therapeutic interventions.”  This chapter 
describes a research platform (WINCS Harmoni) developed to 
measure and characterize real-time in vivo neurochemical activity across 
multiple anatomical targets to improve understanding of normal and 
pathologic brain function and help develop novel personalized therapeutic 
interventions. The work provides new methods and technology in the 
areas of neuromodulation and the treatment of neurologic and 
psychiatric disorders.  The author has led the engineering efforts for 
the development of WINCS Harmoni, which can measure and 
characterize real time in-vivo changes in neurochemical activity 
across multiple anatomical targets and can provide real-time feedback 
to control neurochemical levels.    
 
We show the measurement of both dopamine and serotonin using 
WINCS Harmoni using carbon fiber electrodes.  The measurement of 
serotonin is preliminary, but is consistent with the work by Hashemi 
and Wightman (23).  Further work will be necessary to provide 
serotonin recording and is beyond the scope of this thesis. 
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CHAPTER 5: BORON DOPED DIAMOND 
ELECTRODES 
 
Boron-doped diamond microelectrodes have been utilized for in vitro 
(24-31) and in vivo (32-34) neurochemical detection. Noticeably, 
using diamond microelectrodes, Suzuki et al. recorded dopamine 
release from the corpus striatum of a mouse brain following electrical 
stimulation of medial forebrain bundle (32); Yoshimi et al. monitored 
dopamine transients in response to a reward cue in the striatum of a 
monkey (34); Park et al. measured norepinephrine release from the 
sympathetic nervous system (24); Singh et al. revealed important 
differences in brain serotonin transport function associated with 
genetic variability (28); and Xie et al. examined pharmacologically 
induced adenosine release from a brain slice (25).  In these 
applications, boron-doped diamond, as an electrode material, 
demonstrated unique electrochemical properties, such as a wide 
potential window, low baseline current, inert surface chemistry, and 
thus excellent stability. However, none of these studies utilized fast 
scan cyclic voltammetry. 
 
The electrochemical water window is the range of voltages between 
the voltage at which oxygen is evolved and that at which hydrogen is 
evolved when a voltage is impressed upon a conducting material.  In 
comparison, graphite (pyrolytic carbon) evolves oxygen above 1.12 
volts and hydrogen below -0.99 volts (35) and Boron Doped Diamond 
evolves oxygen above 2.30 volts (36, 37) and hydrogen below -1.10 
volts (37, 38). Between those voltages, accurate measurements can be 
made. 
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The use of carbon fiber microelectrodes is fraught with difficulty; the 
fragility of the electrode, the narrow electrochemical water window 
and the erosion of the electrode material during use led to selection of 
electrically conductive diamond as the electrode material of interest. 
 
5.1 BIOCOMPATIBILITY OF DIAMOND AND DIAMOND LIKE 
CARBON
The active electrode surface being developed for implantation for 
neurochemical detection is composed of boron doped diamond. These 
electrodes for acute human fast-scan cyclic voltammetry recordings 
are being developed in two stages.  The initial design is a modification 
of the FHC (Bowdoin, ME, USA) electrodes that are currently used in 
electrophysiological monitoring as a precursor to implanting the 
permanent DBS electrode. The materials and construction techniques 
are the same, and the electrode jackets used are produced by the same 
vendor (FHC).  For this reason, a discussion of the electrode’s overall 
safety is critically a discussion of the safety of the diamond coating, as 
other elements of the electrode design has already been determined 
to be safe for regular surgical use.  
 
Diamond and diamond-like carbon are materials that are of biological 
interest as bulk materials or as surfaces available to living cells.  
Diamond-like carbon is typically used as a coating for a variety of 
purposes, such as anti-friction coatings on devices which may 
experience wear (for example, on the surfaces of hard disks), devices 
which need corrosion resistance, or resistance to abrasion.  The 
material exhibits sp3-hybridized electron orbitals characteristic of 
diamond as well as amorphous carbon (sp2) bonds.  Coatings of 
diamond, on the other hand, are polycrystalline, and consist entirely 
of micron-sized (or smaller) crystals of covalently-bonded carbon 
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atoms with sp3 orbital hybridization (as determined by Raman 
spectroscopy). 
 
While use of these materials in medical implants is still a reasonably 
new field, and use of them in neural electrodes is more novel still 
(hence the value of this study), it is not entirely unprecedented, and 
the literature – as well as general do electrochemical considerations – 
offers some insight into material safety.  
 
An early study (39) describes the use of diamond-like carbon as an 
inert coating suitable for biomedical devices such as orthopedic 
implants (where the physical strength, wear resistance and lubricity 
of diamond would be advantageous).  This investigation 
demonstrated that cells being cultured did not demonstrate any 
adverse effects.  Additional studies (40, 41) report that, in vitro, 
macrophages, fibroblasts and osteoblast-like cells had normal 
morphology and cellular growth. 
 
A study using a neuroblastoma cell line in vitro (42) showed that after 
48 hours of cell growth, nanocrystalline diamond surfaces 
demonstrated 20% and 58% higher growth than fused silica surfaces, 
with or without fetal bovine serum (FBS) addition.  These authors 
concluded that boron doped nanocrystalline diamond would be 
acceptable for biomedical purposes.  An in vivo study using 
intraperitoneal implants of diamond, 316 stainless steel, and titanium 
in mice (43) showed that there was less cellular adhesion and cell 
activation on chemical vapor deposited diamond compared with 
titanium or stainless steel surfaces.  This evident biocompatibility, 
coupled with the corrosion resistance and notable mechanical 
integrity of CVD diamond, suggests that diamond-coated surfaces may 
be highly desirable in a number of biomedical applications. 
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These reports of general inertness are in agreement with theoretical 
chemical considerations, as diamond crystals are in effect, single, 
covalently-bonded carbon molecules.  As crystals of carbon, when 
subjected to the electric field of fast-scan cyclic voltammetry, their 
only degradation product would be (at most) micromoles/second of 
CO2, of which the body is readily able to dispose.  In this regard, a 
diamond coating would be among the safest materials one could 
possibly use for electrode construction, since no metal ions could be 
deposited in the tissue. 
 
From the standpoint of degradation, these electrodes would also be 
superior to the existing carbon fiber electrodes which have already 
been approved by the Mayo Clinic Internal Review Board (IRB) and 
employed at Mayo Clinic (under the original iteration of this IRB 
protocol), as our own studies (see Figure 5-1 and Figure 5-2) show 
that carbon fiber degrades far faster than diamond.  As has been 
referenced in the introduction, Takmakov et al. demonstrated the 
degradation of the carbon fiber microelectrodes with continued use 
(9). 
  
Of importance is the substrate upon which the diamond coating is 
grown.  Tungsten as an implantable material has been used for many 
years in long-term chronic implants.  However, there is concern as to 
its ability to continue to detect neuronal activity for decades of years.  
It has been reported that insulation damage occurs with longer term 
implantation, and that there is an indication of neuroinflammatory 
response (44).  However, indications are that by replacing the 
polyimide insulation used in the study with parylene-C and a hermetic 
coating of diamond should prevent the activation of cells, which if 
activated, would result in an inflammatory response. 
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When subjected to the FSCV waveform (-0.4 V to +1.3 V vs. Ag/AgCl at 
400 V/s) for an extended period, carbon fibers (Figure 5-1) eroded 
(2) (45),  Our data, shown below, track carbon fiber electrodes before 
use and after 3 days of FSCV in vitro. 
 
 
 
Figure 5-1: Carbon fiber FSCV electrode before use. Source: Mayo Neural 
Engineering Laboratories. 
 
 
 
 
Figure 5-2: Used carbon fiber electrode as in Figure 5-1 after three days of 
use.  Note the carbon fiber electrode becomes thinner with use as the carbon 
is eroded. Source: Mayo Neural Engineering Laboratories. 
 
 
In conclusion, data from the reviewed literature do not reveal any 
specific risks concerning diamond for use as an electrode material. 
 
Carbon nanotubes and carbon nanofibers are materials of interest in 
the development of electrodes for FSCV (46), however in our 
laboratory’s experience (unpublished), the nanotubes and nanofibers 
have the same dissolution issue as other sp2 carbon materials.  
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Examination of the electrodes available commercially or described in 
the literature do not have the characteristics of longevity and 
toughness for safety, implantation or long term use.  Electrodes with 
pyrolytic carbon will dissolve quickly, unless they are utilized at a low 
voltage, preventing the analysis of some electroactive substances of 
interest in the treatment of patients. 
 
Table 5-1: Characteristics of neurotransmitter detection electrode 
materials, showing that diamond is the only material providing all the 
characteristics for the possibility of long term success.  While 
platinum is not useful for FSCV, it was included for comparison 
purposes. 
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Neurotransmitter 
Adsorption 
+ + + + + + - 
Oxidation Resistance - - - - - + + 
Potential for Metal Ion  + + + + + + - 
Electrical Conductivity - + - - + + + 
Biocompatibility - - + + + + + 
Insulation - - - + + + + 
Strength for Implantation + - - - + + + 
 
 
Diamond electrodes reported in the literature typically are not 
evaluated to such an extent as to provide actual analysis of the 
diamond composition or to report the pyrolytic, graphite or 
amorphous carbon content, nor does there seem to be significant 
analysis of residual stress, making the use of those electrodes difficult 
to justify, due to the unanswered possibility of failure. Typically 
references to diamond electrodes provide little analysis of the 
diamond produced, except to note that the electrodes are diamond 
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containing. Rather than examining the surface features, the 
publications appear to report an average measurement of 
crystallinity, not evaluating the locations where the coating can fail, 
such as at the inter-crystalline boundaries. 
5.2 DIAMOND REACTOR DEVELOPMENT 
Diamond thin films were somewhat of a novelty when disclosed by 
W.G.Eversole (US Patent 3,030,187 and 3,030,188, 1962) as a gas 
phase, low pressure route to diamond.  These basic discoveries were 
not substantially exploited until the 1980’s to produce films for a 
variety of industrial purposes such as cutting tools. 
 
Upon determination that the boron doped diamond electrode surface 
appeared to be a viable option for the development of a FSCV 
electrode system that could meet the requirements of longevity and 
sensitivity, conversations were initiated with other laboratories that 
had developed boron doped diamond. An evaluation of that diamond 
was completed utilizing mapping Raman spectroscopy for 
characterizing the surface to determine the amount of amorphous 
carbon contaminant in the films produced. It was decided that a 
collaboration would not be pursued, and that the films should be 
generated internally to Mayo Clinic for human trials. 
 
The phase diagram for carbon, shown in Figure 5-3, below, indicates 
areas of stability of diamond in relation to pressure and temperature.  
Also indicated (lower left) is a metastable area indicating the 
operating temperatures and pressures in which the experiential 
formation of diamond exists for the low pressure reactor. A diamond 
chemical vapor deposition (CVD) reactor was designed to operate in 
this regime of temperatures on the order of 800oC and 
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subatmospheric pressure. It is apparent from the diagram below, that 
there would be competing reactions with the formation of graphite. 
 
Figure 5-3: Stability of Carbon Chart (including diamond and graphite).  
Source: J. Geophys Res. 85 (B12) (1980) 6930. 
 
In reviewing publications utilizing FSCV diamond electrodes in vivo, 
the quantification and description of the materials used is very 
limited.  Many of the publications used amperometery, unsuitable for 
long term operations: 
 
Park et al. 2006 describe the use of amperometry with a diamond 
microelectrode, with the benefits of not requiring pretreatment or 
polymer coatings, background current was low, there was a high level 
of stability in biological environments and no need for  protective 
polymer films such as Nafion.  Preparation of the boron doped 
diamond was on platinum wire utilizing an ASTex, Woburn, MA 
Microwave CVD reactor.  No characteristics of the film were described 
except deposition conditions and polypropylene insulation (47). 
 
5-9
 
Park et al. 2006 describes the fabrication and electrochemical 
characterization of a boron doped diamond microelectrode.  The 
construction was on a 76 micron platinum wire using microwave 
assisted CVD, ASTex, Woburn, MA.  This paper described a post 
growth treatment with hydrogen plasma to remove sp2 carbon 
impurities.  It estimated boron doping levels in the 1019 to 1020 cm-3 
range, again with polypropylene insulation.  SEM analysis and Raman 
spectroscopy (at a single spot) was used for evaluation of the coating.  
The authors report no shift of peak frequency indicating no tensile or 
compressive stress.  The reported spectra indicate some sp2 carbon, 
present in the coatings (48). 
 
There are several diamond electrode constructs in the literature that 
predate this work.  Roham et al. 2007 described a diamond and 
tungsten microneedle; however, the device is constructed with 
quartz glass insulation and suffers from the loss of the diamond 
which was deposited at the end of the construct (49).  It is 
anticipated that this structure would not be appropriate for human 
use since the quartz glass insulation could fracture and be deposited 
in deep brain tissue, which would be unrecoverable.  Dong et al. 2009 
describe the comparison of carbon fiber and diamond 
microelectrodes, but the only description was of the use of 
polypropylene insulation, and diamond production by microwave 
assisted CVD. No analysis of the diamond was reported (50).  This 
device would not be appropriate for human use and it is unclear as to 
the composition of the material deposited.  Pasquarelli et al. 2011 
describe a comparison of nanocrystalline diamond and single crystal 
diamond for simultaneous detection using a quadrupolar device 15 
microns in diameter that they created on a 4x4 millimeter substrate 
(51). This construction would be too large for clinical use and would 
physically disrupt the brain. 
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Hebert et al. 2015 describe neural interfaces made of boron doped 
diamond as a substitute for platinum in functional imaging (52).  The 
application is for boron doped diamond’s electrical conductivity, 
delivering substantial currents, rather than to measure small 
oxidation and reduction reactions currents.  While intriguing, these 
works do not anticipate the structure and use of diamond for long 
term implantation and the treatment of disease.
5.3 DIAMOND REACTOR DESIGN 
Before attempting to design and construct a diamond CVD reactor, 
several research groups’ diamond films were evaluated for use in the 
electrode design.  Films were evaluated by scanning electron 
microscopy and Raman mapping to determine the composition of the 
film in diamond and non-crystalline carbon terms.  It was determined 
that the amount of amorphous carbon in the samples would likely 
render the films unstable under operating conditions, as the non-
diamond carbon would dissolve during conditions of use.  It was 
decided that since the boron doped diamond films play such an 
integral part in the design, control of the diamond production was 
needed.   
 
There are a variety of reactor technologies; high purity film producing 
systems are based upon plasma production at temperatures on the 
order of 2000o C with quenching of the reactive species at 
approximately 800o C, causing carbon containing radicals to crystalize 
as diamond with varying crystal morphologies.   
 
Experience with current reactor designs (microwave and hot-
filament) showed issues of controllability with microwave designs.  
Issues with the existing hot-filament designs were that the hot-
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filament was positioned above the substrates, making the electrodes 
susceptible to contamination from any material dropping from the 
filament. 
 
The author conceived, designed and collaboratively built a reactor for 
the formation of diamond specifically for development of a human 
testable electrode to be used in FSCV for the detection of 
neurochemicals.   
 
The main options for the deposition of diamond films are: 
 
x Hot Filament Chemical Vapor Deposition (CVD) 
x Direct Current Plasma CVD 
x Radio Frequency Plasma CVD 
x Microwave Plasma Enhanced CVD (MWCVD)  
x Electron Cyclotron Resonance Microwave Plasma CVD 
 
While no technique is perfect for all deposition requirements, the 
decision was made for this research to utilize the technique of hot 
filament chemical vapor deposition since it is more directly 
controllable compared to other plasma sources, a more compact 
reactor system could be developed, and a more cost effective 
construction could be accomplished. 
 
A novel horizontal reactor was designed; the body of the reactor is 
borosilicate glass, with an integral water jacket to control the 
temperature of the reactor body, keeping the surface temperature 
near room temperature (approximately 20oC) to reduce outgassing 
and contamination.  The reactor was configured with ports at both 
ends, one end containing the electrical feed through to support and 
power the filament and the other end containing the support 
structure for electrode substrates.  The holding system was designed 
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to hold flat (silicon and tungsten) substrates, as well as up to 8 
pointed wire (tungsten) electrodes for coating with diamond.  
 
Computer controls for the reactor with data logging allows 
monitoring the deposition process to increase the yield and 
uniformity of the deposition, with repeatability due to monitoring and 
feedback control. 
 
The design is based on a horizontal reactor, (allowing particulates to 
drop from the active reaction volume and not contaminate the 
electrodes being fabricated), allowing easy access to loading the 
electrodes to be coated with diamond and for renewing the filament. 
The flange design allows fairly quick modifications of substrate 
systems as well as filaments.  Borosilicate glass was selected for ease 
of reactor design and fabrication, for its transparency and for avoiding 
potential metals contamination with a structure and a configuration 
unconstrained by the availability of commercial metal fittings.  
Temperature control of the reaction vessels walls was easily 
accomplished by a double wall cooling jacket construction with 
circulating water.   Glass provided additional safety due to its non-
conductive nature at moderate temperatures.  In addition future 
reactor conditions may require modifications to provide substrate 
biases which can be more easily implemented. 
5.4 DIAMOND CVD REACTOR
Figure 5-4, below, shows the engineering drawings of the hot filament 
vacuum chamber constructed of borosilicate glass.  The chamber 
walls are kept cool via an integral jacketed cooling system.  Gas 
handling ports are at each end to allow entry of the reactive gasses at 
the hot filament end of the reactor (to the right) and the vacuum 
exhaust port on the left.  The large flanges at each end allow access to 
5-13
 
the inner chamber.  The port on the vertical centerline allows visual 
access to the hot filament, by which temperature control can be 
accomplished by measuring black body light emission. 
 
Figure 5-5 shows an image of the diamond reactor prepared for 
operation, with the gas, cooling and electrical support connections. 
 
Figure 5-6 and Figure 5-7 show, respectively,details of the substrate 
holder for the diamond deposition and the filament in the filament 
holder for generation of the high temperature required to initiate 
diamond deposition. 
 
Figure 5-4: Diamond reactor vacuum vessel design.  Borosilicate glass 
double wall for water cooling. (6) outside cooling jacket wall, (5) inner 
vacuum vessel wall, (7) two flanges for attaching substrate holder and 
electrodes, (9) hose barbs for coolant and (10) dual gas handling ports. 
Source: Mayo Division of Engineering. 
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Figure 5-5:  Image of CVD diamond reactor showing water cooling jacket, 
mixed reactive gas introduction on the right, vacuum exhaust on the left.  
Right flange has the high current electrodes for powering the filament.  Left 
flange has molybdenum post feedthrough allowing water cooling of system 
as well as rotation to provide for more uniform coating of substrates. 
 
 
Figure 5-6: Adjustable molybdenum substrate holder showing holder for 
multiple electrodes and thermocouple fixturing, as well as adjustment 
technique for changing the distance of the substrate from the filament. 
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Figure 5-7: Close up of tungsten filament holder of molybdenum with 
tungsten wire filament supports, allowing movement of filament due to 
thermal expansion while maintaining filament positioning relative to the 
experimental sensing electrodes. 
 
 
The distance between the deposition substrate and the filament is 
adjustable so that the substrate can be positioned within the diamond 
deposition (plasma recombination) zone.  Figure 5-8 shows the CVD 
reactor in operation with the filament meeting the 2000o C 
temperature requirement. 
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Figure 5-8: CVD reactor in operation during deposition of polycrystalline 
boron doped diamond on tungsten electrodes. 
 
During exploration of initial reactor deposition conditions, crystals 
were formed on the ends of a sharpened tungsten wire.  The initial 
analysis confirmed this material to be crystalized carbon, diamond. 
 
Using the EDAX (Energy Dispersive X-ray Spectroscopy) equipment 
installed with the SEM, elemental analysis was performed. Figure 5-
10, below, shows the elemental analysis of the tip of the electrode 
with the crystals.  In EDAX, characteristic X-ray spectra are emitted by 
the elemental constituents a the surface being analyzed as electons 
from the SEM’s high voltage source impinge upon it.  The spectrum 
below identifies a preponderance of carbon with a trace of potassium. 
 
Figure 5-10 shows the spectrum obtained from observation of the 
tungsten wire, showing the preponderance of tungsten with a variety 
of trace elements associated with the metal wire, including iron, 
potassium, oxygen, chlorine, and sodium. Figure 5-11 is a SEM 
imaging showed excellently formed crystallites in the micron size 
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range.  Figure 5-12 shows an electrode that has been insulated, 
leaving only the active area of the electrode system exposed for use in 
FSCV analysis. 
 
 
Figure 5-9: Elemental analysis using EDAX within a Hitachi S4700 electron 
microscope to determine the composition of the diamond coating.  Other 
than carbon, trace amount of potassium was detected. 
 
 
 
 
 
 
 
Figure 5-10: Elemental analysis using EDAX within a Hitachi S4700 electron 
microscope to determine the composition of the substrate.  This spectrum 
confirms the tungsten composition of the substrate, with other trace 
elements present. 
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Figure 5-11: Diamond as deposited on tungsten by Mayo diamond reactor, 
showing microcrystalline diamond film. Source: Mayo Neural Engineering 
Laboratories. 
 
 
 
 
 
 
Figure 5-12: Diamond electrode after insulation with polyimide, through 
hand application and oven curing of the polymer. Source: Mayo Neural 
Engineering Laboratories .
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It is important to note that the typical CFM are typically around 7 
microns in diameter while the manufactured diamond electrode of 
this work is a conical structure of about 50 microns at the base.  A 
disadvantage of this is that the exquisite spatial resolution afforded by 
the 7 micron diameter fiber is lost when utilizing an electrode of 50 
microns.  However, the advantage of the enhanced physical 
robustness provided by the increased diameter, tungsten under 
structure and lack of etching has value in actual surgical implantation. 
Further study will be required to delineate the in vivo characteristics 
of the increased diameter.  If the increased diameter is problematic, 
the engineering solution of making the electrode thinner is not 
insurmountable and is relatively straight forward. 
 
5.5 DIAMOND REACTOR FABRICATION 
The included paper, “Chemical Vapor Deposition Reactor for Diamond 
Deposition” published in the Proceedings of the 60th Symposium on 
the Art of Scientific Glassblowing, describes in detail the specifics of 
the construction of the diamond reactor, detailing the unusual seals 
required to create the water jacket of the reaction vessel. 
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CHAPTER 6: ANALYSIS OF DIAMOND 
MATERIAL 
 
The publication “Development of Conductive Boron-Doped Diamond 
Electrode:  A microscopic, Spectroscopic and Voltammetric Study” in 
the journal Materials describes the work accomplished to improve 
the properties of the diamond electrode material.  Several techniques 
are applied to the diamond films, including the more conventional 
techniques of Scanning Electron Microscopy (SEM), infrared 
absorption spectroscopy and confocal Raman mapping microscopy, 
with a final demonstration of the electro activity via the detection of 
neuro chemicals utilizing FSCV. 
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CHAPTER 7: DRUDE MODEL OF 
CONDUCTIVITY 
 
The publication, “A Drude model analysis of conductivity and free 
carriers in boron-doped diamond films and investigations of their 
internal stress and strain” in the Journal of Materials Science 
examines an alternative process for examining conductivity through 
boron carrier concentrations and time constants of the materials 
produced.  The four point probe method of measurement of 
conductivity is problematic, since the physical size of the electrodes 
is small and they are conical in shape.  Far-IR transmittance provided 
additional information such as the creation of carriers or the creation 
of defects in the diamond lattice. 
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CHAPTER 8: RAMAN ANALYSIS OF 
INTERNAL STRAIN 
 
The diamond electrodes were evaluated by mapping with Raman 
spectroscopy to determine electrode surface concentrations of 
diamond, boron and non-diamond carbon (sp2 containing graphite, 
pyrolytic carbon, amorphous carbon).  By mapping the electrodes 
before and after use, changes in surface activity and composition 
caused by use and resulting chemical reactions can be detected. 
 
Further, scanning electron microscopy was utilized to examine 
diamond crystallite size, examine the surface for imperfections and 
observe how the electrodes respond to use. 
 
The electrodes were subjected to multiple cycles of FSCV to provide 
data on longevity.  A multi electrode testing fixture was envisioned 
and constructed, allowing a number of electrodes (up to 16 at one 
time) to be simultaneously cycled through the FSCV technique at very 
high speed, performing millions of cycles of measurement over days 
of operation in vitro. 
 
The lifetime of electrodes is envisioned to require 30 years of human 
implantation service since individuals receiving DBS therapy require 
this for the duration of treatment (lifetime), as the therapy is not 
curative.  While real time measurements can be performed at speeds 
on the order of 9.5 ms, with 100 ms between pulses (10 times per 
second), it is not yet clear what sampling frequency will be needed 
for a therapeutic feedback loop DBS system.  If readings are required 
at 1 second intervals for therapy, a 30 year life requires on the order 
of 946 million cycles.  However, if for treatment, sampling can be 
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reduced to once every 10 minutes, the lifetime requirement would be 
on the order of 1.6 million cycles. 
 
At our currently achievable cycling frequency of once every 100 ms, 
1.6 million test cycles, can be completed in 1.8 days (to mimic 
treatment measurement at once per 10 minutes), while to cycle for 
the equivalent of 30 years at one clinical test per minute would 
require 18 days of accelerated testing. 
 
There is a thermal expansion mismatch between tungsten and 
diamond.  Because the coefficient of linear expansion, alpha, is on the 
order of 4.4 for tungsten and on the order of 1.1 for diamond, there 
are concerns that this mismatch may create residual stress, 
potentially resulting in delamination (53).  Since the diamond coating 
is created at temperatures in the range of 800o C, and is operated at 
human body temperature, 37o C, there may well be substantial 
residual stress created by the manufacturing process.  Raman 
techniques will be utilized to measure residual stress, and electrodes 
will be sectioned and examined via scanning electron microscopy to 
examine for delamination that could occur.   
 
The third publication concerning diamond produced in the reactor is 
“Raman Microscopic Analysis of Internal Stress in Boron-Doped 
Diamond” which was published in Materials.  This publication 
examined induced stress of deposition of undoped and boron-doped 
diamond thin films utilized in the creation of the electrodes for the 
detection and measurement of neurochemicals.  This stress can arise 
from atomic composition and mismatch between the atomic lattices 
of the tungsten substrate and the diamond.  Diamond film 
delamination during implantation could create unwanted problems 
for the implantation and data collected.   
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The following article, “Raman Microscopic Analysis of Internal Stress 
in Boron-Doped Diamond,” which was published in Materials 
describes the use of confocal Raman microscopy in our work. 
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CHAPTER 9: RAMAN ANALYSIS OF 
NEUROTRANSMITTERS 
 
During examination and evaluation of the work accomplished in the 
previous chapter, Raman based optical approachs may provide an 
interesting system to be used in adjunct with FSCV or a stand-alone 
method for neurochemical detection.  Benefits may include less 
rejection by the body, and highly accurate absolute measurements of 
many more analytes than would be possible with FSCV, since the 
detection method does not depend upon electroactivity.  In 
exploration of this concept, a publication was created, entitled 
“Detection and Monitoring of Neurotransmitters – a Spectroscopic 
Analysis,” published in Neuromodulation.  The article describes how 
Raman spectroscopy can effectively differentiate adenosine, 
dopamine, and serotonin. 
 
My ongoing work in a parallel path is examining operating conditions 
and structures of fiber optic probes incorporating nanomaterials to 
utilize SERS to improve the sensitivity of Raman detection of 
neurochemicals and other compounds of interest.  Benefits include a 
much larger palette of chemical analytes that can be detected, and a 
postulated non response of the body to the measurement of analytes 
since the brain has no natural photon detectors.  It is further 
anticipated that the body will respond less to the intrusion of the 
fiber optic and that the speed of detection will be much greater. It is 
anticipated that this technology, requiring substantial development 
may well be a substantial addition to the research and clinical 
armamentarium for detection and monitoring of neurochemicals. 
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CHAPTER 10: HUMAN IMPLANTATION 
 
In the included publication “A Diamond-Based Electrode for 
Detection of Neurochemicals in the Human Brain” published in 
Frontiers in Human Neuroscience, the goal of detection of human 
neurochemicals is accomplished in four human patients.  This 
publication demonstrates the detection of neurochemicals in the 
human brain, a major step in the development of a feedback system 
connecting detection to neurostimulation.  Use of the diamond 
electrodes with their physical robustness (two orders-of-magnitude 
greater than carbon fiber electrodes) and demonstrated longevity in 
vitro is also highlighted in the electrodes’ deployment in thalamic 
targets in human. 
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CHAPTER 11: SUMMARY, 
CONCLUSIONS, AND FUTURE 
DIRECTION 
 
The primary thrust of this thesis was: How can Fast Scan Cyclic 
Voltammetry sensing electrodes suitable for long term implantation 
in the human brain be created?  My central hypothesis was that 
Boron doped diamond is suitable for long term FSCV recordings in 
the human brain for measurements of neurotransmitter release 
demonstrated during DBS neurosurgery.   My research work 
designed and developed Fast Scan Cyclic Voltammetry sensing 
electrodes based on boron doped diamond for the first time, that 
were suitable for long term implantation in the brain.  Novel 
electrode compositions allowed the quantitative measurement of 
neurotransmitter release for sustained periods of time in the rat, the 
pig, and the human brain. 
 
The major contributions from this thesis include the following: 
1. Boron doped diamond is suitable for FSCV sensing using the 
novel WINCS monitoring devices. 
2. Boron doped diamond has the necessary longevity to allow 
implantation for long term human implantation. 
3. Adenosine was indeed released during DBS lead insertion in 
human patients as measured by WINCS and carbon fiber 
microelectrode and boron doped diamond. 
4. The boron doped diamond can be fabricated in high volume 
using our novel diamond reactor. 
5. It is possible to develop feedback loop sensors using boron 
doped diamond electrodes. 
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While boron-doped diamond electrodes have been developed for 
electrochemical sensing, they have been limited to use for periods of 
hours, potentially days, at low usage intensity in vitro and in vivo 
(predominately rats and brain slices), but not in humans.  My 
research work determined electrode fabrication techniques that 
demonstrably resulted in the ability of the boron-doped diamond 
electrodes to function for the millions of cycles that will characterize 
a long term study, and the successful measurement of 
neurotransmitters in the human brain. The near term value is 
anticipated in preclinical studies where we can measure 
neurochemistry in essentially real time. It is planned that this 
development of an electrode that is usable in humans will provide 
the breakthrough needed to allow the creation of DBS with feedback 
to be used to manage current application of DBS in neurologic and 
psychiatric diseases. 
 
During this body of work, I described the importance of electrodes as 
the point of interface between human biology and engineered 
electronic systems, providing the background for current 
technological state of art in stimulation and sensing electrodes.  
Then, I described the electrochemical technique of fast scan cyclic 
voltammetry, the engineering design, and the capabilities of the Mayo 
developed Wireless Instantaneous Neurotransmitter Concentration 
System (WINCS) and Mayo Investigational Neurostimulation Control 
System (MINCS).  In line with electronics development, I described 
new methods and technology that led to the engineering 
development of WINCS Harmoni, which can measure and 
characterize real time in-vivo changes in neurochemical activity 
across multiple anatomical targets and can provide real-time 
feedback to control neurochemical levels. I then went on to describe 
the development and operation of the chemical reactor system used 
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to create the boron doped diamond electrode. Much work was 
presented analyzing the diamond film structure and boron doping of 
the active component of the electrode, describing the metal like 
behavior of diamond containing boron, using techniques of far infra-
red spectrometry, and evaluating the incorporated stress and strain 
in the diamond film, allowing evaluation of long term stability of the 
substrate/diamond interface.  My final component of this thesis was 
the exciting application of the diamond-based electrode for 
measurement of neurochemicals released in the human brain during 
DBS neurosurgery.   
 
There are also important limitations of this thesis that should be 
pointed out: 
 
1.  The boron doped diamond currently has significantly lower 
sensitivity to analytes than carbon fiber. The longevity of the Boron 
Doped Diamond is far superior to carbon fiber when the voltage 
window for FSCV analysis is expanded above the water window of 
carbon fiber to allow detection of additional analytes. Sensitivity 
improvements such as modification to boron doping level and signal 
processing are anticipated to improve the detection limits 
significantly. 
2. The current size of the electrode is significantly larger than 
the Carbon Fiber Microelectrode, however, production of significant 
smaller diamond electrodes are in the realm of possibility. 
3. The optimal level of the neurotransmitters for closed loop 
control has not yet been determined.  Moreover, it is principally for 
this reason that we developed this technology for research and 
ultimately human treatment. 
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For the future, it is clear that DBS technology will include feedback 
control for enhanced operation and improvement in battery life.  
Indeed, feedback control is already appearing in devices for the 
treatment of epilepsy, where electrophysiology is being monitored 
to trigger stimulation for control of seizures only when required.  
The work outlined in this thesis demonstrates the exciting 
possibility of a neurochemical feedback system that incorporates 
boron diamond chemical sensors that can last the duration of the 
patients lifetime.  Such systems may be used for treatment of 
psychiatric illness where emotional circuit modulation is envisioned 
for treatment of disorders such as Obsessive Compulsive Disorder 
(OCD), depression, Tourette’s, drug and alcohol abuse and perhaps 
even to enhance cognitive ability.  
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